CARBAMAZEPINE
- Product NDC
- 66267-278
- 11-digit product format
- 662670278
- Labeler code
- 66267
- Product ID
- 66267-278_9cbdbe41-134d-6938-e053-2a95a90ae941
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CARBAMAZEPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA077272
- Marketing category
- ANDA
- Marketing start
- 2009-10-23
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66267-278-30 | 66267027830 | 30 TABLET in 1 BOTTLE (66267-278-30) | 30 tablet | 2016-11-08 | 0000-00-00 | No | No | Current |
| 66267-278-90 | 66267027890 | 90 TABLET in 1 BOTTLE (66267-278-90) | 90 tablet | 2016-11-08 | 0000-00-00 | No | No | Current |